Thursday 26 September is the inaugural Childhood Brain Cancer Awareness Day. This year, we shine a light on Diffuse Intrinsic Pontine Glioma (DIPG), the most devastating of all childhood cancers.
The 9th International Nanomedicine Conference was held last week in Coogee, Sydney. Some of our researchers were there, showcasing their research and networking with colleagues from near and far.
NSW Health Minister Brad Hazzard has announced a $1 million funding boost for the Zero Childhood Cancer program. The money will support an immunotherapy trial for children with brain cancer.
A childhood brain cancer called diffuse intrinsic pontine glioma (DIPG) is currently incurable. Our researchers have identified a new treatment that may help change that.
Brain cancers are the leading disease-related cause of death in Australian children. In this article, first published in The Conversation, A/Prof David Ziegler explains what we can learn from improving childhood leukaemia survival.
In a landmark moment for brain cancer research, the Australian Government has established a $100 million fund to search for cures and support clinical trials.
In this second post in our series for Childhood Cancer Awareness month, see how we apply the basics about childhood cancer to search for better treatments.
Brain tumours are among the deadliest childhood cancers and Diffuse Intrinsic Pontine Glioma (DIPG) one of the most aggressive. But we’re making progress in the search for effective treatments.
In the second post in a series profiling our emerging researchers, we meet Dr Han Shen who's researching treatments for children with a terrible cancer.
An award for our brain cancer team recognises research into one of the nastiest childhood cancers. Our team will test potential new treatments on tiny soccer balls of cells.